Nexstim has a platform TMS technology with multiple applications and position as a premium priced system differentiated by e-field navigation. In diagnostics we have already over 170 installed NBS Systems around the world and now we are focused on maximising the potential of SmartFocus® TMS in therapy.
Therapy
Objective: recurring revenue optimization through existing installed base and profitable new system growth in major depressive disorder (MDD) and chronic neuropathic pain. Launching a new severe depression indication business based on an accelerated therapy protocol.
- Therapy Scope: Leverage this platform technology around selected therapeutic indications in selected markets (focus in the USA & EU) with new and existing TMS service providers:
- Treatment of MDD and severe depression
- Treatment of chronic neuropathic pain
Diagnostics
Objective: recurring revenue growth through existing strong installed base and new sales development mainly through strategic partnerships
- Diagnostic Scope: Further develop this technology around motor and speech mapping of the brain in selected diagnostic indications in selected markets (focus in the USA & EU) with the world’s leading hospitals:
- Preprocedural planning for difficult brain tumour and epilepsy patients
- Planning for patients undergoing radiotherapy for brain tumour
Diagnostic and Therapy Advantages
These selected diagnostic and therapeutic applications represent indications where:
- Nexstim technology demonstrates recognisable clinical outcome and customer profitability
- Hospital inpatient treatments are usually required
- Integrated and easy to use navigated TMS device enables a future platform in other indications from day one